Articles tagged "Metabolic disease"

2018 American Transplant Congress
Metabolic Acidosis after Kidney Transplantation: Prevalence, Risk Factors and Graft Outcome in a French Cohort
F. Garo, I. Szwarc, G. Mourad, M. Le Quintrec, J-.E. Serre.
Nephrology, University Hospital of Montpellier, Montpellier, France.
Background: Metabolic acidosis (MA) lead to several complications in more advanced stages of chronic kidney diseases (CKD) and promotes CKD progression. Acidosis is a common…
2018 American Transplant Congress
How Evaluation for Living Kidney Donation Saved My Life
M. Guthoff,¹ T. Mühlbacher,¹ S. Nadalin,² N. Heyne.¹
¹Dept. of Endocrinology and Diabetology, Angiology, Nephrology and Clinical Chemistry, University of Tübingen, Tübingen, Germany; ²Dept. of General, Visceral and Transplant Surgery, University of Tübingen, Tübingen, Germany.
Purpose:In order to ensure eligibility for living kidney donation, donor candidates undergo a thorough medical evaluation. This evaluation process might reveal previously unknown medical conditions,…
2017 American Transplant Congress
Outcome of Liver Transplantation in Patients with Prior Bariatric Surgery.
M. Safwan,¹ M. Abouljoud,¹ R. Salgia.²
¹Divison of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI; ²Gastroenterology, Henry Ford Hospital, Detroit, MI
Aim: To study outcomes of liver transplantation (LT) patients with prior bariatric surgery (BS).Methods: Retrospective analysis performed on patients with LT between Jan 2006 and…
2017 American Transplant Congress
Statins in Liver Transplant Recipients: Rates of Use, Mortality and Rejection.
R. Selim,¹ A. Abdulhamid,¹ A. Shyamraj,² A. Watson,² J. Tang,² S.-M. Jafri.²
¹Internal Medicine, Henry Ford Hospital, Detroit, MI; ²Gastroenterology, Henry Ford Hospital, Detroit, MI
Introduction:Liver transplant recipients are prone to developing metabolic syndrome following transplant, likely secondary to immunosuppressant use. Among those with metabolic syndrome, the rate of cardiovascular…
2017 American Transplant Congress
Primary Hyperoxaluria Type-1 in Chinese Population: A Case Series and Review of Literature.
D. Du,^1,2 Q. Li,^1,2 H. Shi,^1,2 S. Chen,^1,2 B. Liu,^1,2 Z. Lin,^1,2 G. Chen,^1,2 F. Zeng,^1,2 W. Zhang,^1,2 Z. Chen.^1,2
¹Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; ²Key Laboratory of Organ Transplantation, Ministry of Health/Education, Wuhan, Hubei, China
Background: Primary hyperoxaluria type 1 (PH1) is rare but devastating autosomal recessive inherited disease and cause to graft failure after kidney transplant (KT). We report…
2017 American Transplant Congress
Prospective Monitoring of 25-Hydroxyvitamin Vitamin D Levels After Kidney Transplantation and Its Associations with Clinical Outcomes.
P. Bedi, N. Hayde, L. Kamal, M. Ajaimy, M. Lubetzky, G. de Boccardo, E. Akalin.
Montefiore Transplant Center, Albert Einstein College of Medicine, Bronx, NY
Background: Kidney transplant recipients usually have low vitamin D levels. Vitamin D deficiency is recognized as a risk factor for progression of kidney disease in…
2016 American Transplant Congress
Hepatitis C Eradication with Sofosbuvir Based Regimens Leads to Significant Metabolic Changes in Post Orthotopic Liver Transplant Patients.
A. Morales,¹ M. Singla,² H. Greenwald,¹ S. Robertazzi,¹ C. Rodigas,¹ V. Washington,¹ R. Satoskar,¹ C. Smith.¹
¹MedStar Transplant Institute, Georgetown University Hospital, Washington, DC; ²Gastroenterology Service, Walter Reed National Military Medical Center, Bethesda, MD.
The purpose of this study was to assess the effect of hepatitis C virus (HCV) eradication with sofosbuvir based regimens on glycemic and lipid control…
2016 American Transplant Congress
Simultaneous Pancreas and Kidney Transplantation for Type 2 Diabetes.
K. Wong, W. Bry, H. Mahanty, P. Patel.
Transplantation, California Pacific Medical Center, San Francisco, CA.
Introduction: Type 2 diabetes (T2DM) is characterized initially by insulin resistance and later by beta cell failure. Historically, T2DM has been a relative contraindication for…
2016 American Transplant Congress
A Successful Approach to Kidney Transplantation in Patients with Secondary Hyperoxaluria.
J. Roodnat,¹ A. Mik-van Egmond,² W. Visser,² S. Berger,³ W. van der Meijden,⁴ F. Knauf,⁵ M. Agteren van,¹ M. Betjes,¹ E. Hoorn.¹
¹Internal Medicine, Erasmus MC, Rotterdam, Netherlands; ²Dietetics, Erasmus MC, Rotterdam, Netherlands; ³Internal Medicine, University Hospital, Groningen, Netherlands; ⁴Internal Medicine, Radboud University, Nijmegen, Netherlands; ⁵Nephrology and Hypertension, Friedrich-Alexander-Universität, Erlangen-Nürnberg, Germany.
Chronic oxalate nephropathy is observed secondary to enteric hyperoxaluria that is associated with malabsorption e.g. in short bowel syndrome. Kidney transplantation can be challenging given…
2016 American Transplant Congress
Resolution of Donor Non-Alcoholic Fatty Liver Disease Following Liver Transplantation.
A. Posner,¹ W. Twaddell,² S. Hanish,² D. Bruno,² W. Hutson,² L. Hebert,² R. Barth,² J. LaMattina.²
¹University of Maryland School of Medicine, Baltimore, MD; ²Division of Transplantation, University of Maryland School of Medicine, Baltimore, MD.
Purpose: Severe and moderate degrees of donor liver steatosis have traditionally limited the transplantation of these organs. The natural history of successfully transplanted livers with…